• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    E.F. Hutton Advises on RPM Interactive's Acquisition by Avalon GloboCare

    12/23/25 10:00:00 AM ET
    $ALBT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ALBT alert in real time by email

    NEW YORK, Dec. 23, 2025 (GLOBE NEWSWIRE) -- E.F. Hutton & Co., a leading investment bank providing strategic advisory and capital markets services, today is proud to have served as exclusive financial advisor to RPM Interactive, Inc. ("RPM") in its acquisition by Avalon GloboCare Corp. (NASDAQ:ALBT). The transaction, completed as an all-stock merger, represents a significant strategic milestone for RPM and underscores E.F. Hutton's continued leadership in advising innovative, high-growth companies across technology and artificial intelligence sectors.

    Under the terms of the transaction, RPM merged with and into Avalon Quantum AI, LLC, a wholly owned subsidiary of Avalon GloboCare, in a transaction valued at approximately $19.5 million. As part of the merger, Avalon acquired RPM's proprietary Catch-Up™ Software-as-a-Service platform, a fully automated generative AI video production system designed to create, publish, and distribute short-form digital content at scale.

    E.F. Hutton & Co. provided comprehensive financial advisory services to RPM throughout the transaction, including strategic evaluation, valuation analysis, transaction structuring, and negotiation support. The engagement highlights the firm's expertise in executing complex mergers and acquisitions involving emerging technologies and publicly traded counterparties.

    "This transaction reflects E.F. Hutton's commitment to advising innovative companies on strategic outcomes that support long-term growth and value creation," said Joseph Rallo, Chief Executive Officer of E.F. Hutton & Co. "RPM Interactive has built a differentiated AI-driven content platform with broad commercial applications. The acquisition by Avalon GloboCare positions the technology for expanded deployment, and we are proud to have supported RPM through this important transaction."

    RPM's Catch-Up™ platform intelligently sources relevant video clips, generates human-like AI commentary, creates on-screen avatars, and publishes finished content across major digital platforms without the need for manual editing or technical expertise. The platform is designed to serve content creators, media companies, and brands across news, sports, finance, entertainment, and other evergreen categories.

    Avalon plans to leverage the Catch-Up™ platform to support and enhance marketing initiatives for its consumer wellness products, including KetoAir™, an FDA-registered breathalyzer designed to help users monitor metabolic health. The integration of RPM's AI-driven content capabilities is expected to accelerate digital engagement and broaden Avalon's audience reach.

    "E.F. Hutton's role in this transaction reinforces our focus on delivering disciplined, execution-oriented advice in rapidly evolving technology markets," Mr. Rallo added. "We remain committed to helping our clients navigate complex strategic decisions and achieve successful outcomes."

    About E.F. Hutton & Co.

    E.F. Hutton & Co. is a Manhattan-headquartered investment bank and broker-dealer delivering sophisticated advisory and capital solutions to corporates, financial sponsors, and public-private partnerships. With a global presence, the firm provides comprehensive investment banking services across capital markets, PIPEs, private placements, mergers and acquisitions, and bespoke strategic financing. E.F. Hutton & Co.'s executive leadership brings a long-standing track record of trusted counsel, supporting clients throughout the United States, Asia, Europe, the UAE, and Latin America.

    Contact Information

    E.F. Hutton & Co.

    [email protected]

    https://efhutton.com

    (212) 970-3700



    Primary Logo

    Get the next $ALBT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALBT

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ALBT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    E.F. Hutton Advises on RPM Interactive's Acquisition by Avalon GloboCare

    NEW YORK, Dec. 23, 2025 (GLOBE NEWSWIRE) -- E.F. Hutton & Co., a leading investment bank providing strategic advisory and capital markets services, today is proud to have served as exclusive financial advisor to RPM Interactive, Inc. ("RPM") in its acquisition by Avalon GloboCare Corp. (NASDAQ:ALBT). The transaction, completed as an all-stock merger, represents a significant strategic milestone for RPM and underscores E.F. Hutton's continued leadership in advising innovative, high-growth companies across technology and artificial intelligence sectors. Under the terms of the transaction, RPM merged with and into Avalon Quantum AI, LLC, a wholly owned subsidiary of Avalon GloboCare, in a tr

    12/23/25 10:00:00 AM ET
    $ALBT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Myseum Completes Sale of Minority Stake in RPM Interactive for Approximately $6.5 Million in Avalon GloboCare Acquisition

    NEW BRUNSWICK, N.J., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Myseum, Inc. (NASDAQ:MYSE) ("Myseum" or the "Company") today announced the completion of the sale of its approximately 34% ownership interest in RPM Interactive, Inc. ("RPM") as part of a 100% acquisition of RPM by Avalon GloboCare Corp. (NASDAQ:ALBT) ("Avalon"). Under the terms of the acquisition, Avalon has agreed to issue 19,500 shares of Series E Non-Voting Convertible Preferred Stock to RPM's stockholders, representing a total purchase price of $19.5 million. Each share of Series E Preferred Stock carries a stated value of $1,000 and is convertible into shares of Avalon's common stock at a $1.50 conversion price, subject to custom

    12/15/25 8:32:00 AM ET
    $ALBT
    $MYSE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Telecommunications Equipment
    Telecommunications

    Avalon GloboCare Acquires RPM Interactive, a Generative AI Software Company, in an All-Stock Transaction

    Company forms a new subsidiary, Avalon Quantum AI, LLC, in connection with the acquisition Acquisition expected to resolve Nasdaq minimum stockholders' equity deficiency RPM Interactive has developed a fully automated, generative AI powered SaaS platform for creating short-form video content FREEHOLD, N.J., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of precision diagnostic consumer products, today announced that it has acquired RPM Interactive, Inc. ("RPM"), a generative artificial intelligence ("AI") publishing and software company, in an all-stock transaction. As a result of the acquisition, the Company believes it

    12/15/25 8:30:00 AM ET
    $ALBT
    $ASPU
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Other Consumer Services
    Consumer Discretionary

    $ALBT
    SEC Filings

    View All

    Avalon GloboCare Corp. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Leadership Update, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Avalon GloboCare Corp. (0001630212) (Filer)

    12/15/25 9:01:03 AM ET
    $ALBT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Avalon GloboCare Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Avalon GloboCare Corp. (0001630212) (Filer)

    12/1/25 9:29:01 AM ET
    $ALBT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Avalon GloboCare Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - Avalon GloboCare Corp. (0001630212) (Filer)

    11/21/25 4:30:51 PM ET
    $ALBT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ALBT
    Leadership Updates

    Live Leadership Updates

    View All

    Fusion Fuel Appoints Luisa Ingargiola to Board of Directors

    DUBLIN, Feb. 27, 2025 (GLOBE NEWSWIRE) -- via IBN – Fusion Fuel Green PLC (NASDAQ:HTOO) ("Fusion Fuel" or the "Company"), a leading provider of gas and hydrogen energy solutions, today announced the appointment of Luisa Ingargiola to its Board of Directors, effective February 24, 2025. Ms. Ingargiola will serve as chairperson of the Audit Committee, replacing Rune Magnus Lundetrae, who will remain a member of the Board. She will also serve as a member of the Nominating Committee, Audit Committee, and Compensation Committee. Following Ms. Ingargiola's appointment, the Board will be comprised of six directors, four of whom have been determined by the Board to be "independent directors" under

    2/27/25 8:00:00 AM ET
    $ALBT
    $HTOO
    $VMAR
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Industrial Machinery/Components
    Energy

    Avalon GloboCare Appoints Dr. Charles Cavo to its Scientific Advisory Board in Support of KetoAir Sales

    FREEHOLD, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative precision diagnostics and laboratory services, today announced that it has appointed Dr. Charles Cavo to its Scientific and Clinical Advisory Board. Dr. Charles Cavo is the co-founder and Chief Medical Officer of Pounds Transformation, founded to help patients successfully reach their health and wellness goals through a combination of medical and lifestyle interventions related to nutrition and exercise. Dr. Cavo specialized in family medicine as an OBGYN at the Hospital of Central Connecticut and was drawn to the challenge of the obesity epid

    10/31/24 9:00:00 AM ET
    $ALBT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    La Rosa Appoints Corporate Finance Executive Lourdes Felix to its Board of Directors

    Celebration, FL, May 21, 2024 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ: LRHC) ("La Rosa" or the "Company"), a holding company for five agent-centric, technology-integrated, cloud-based, multi-service real estate segments, today announced that it has appointed Lourdes Felix to its Board of Directors. Ms. Felix was also appointed to serve as the Chairperson of the Audit Committee and as a member of the Board's Compensation Committee and Nominating and Corporate Governance Committee. Ms. Lourdes Felix is an accomplished entrepreneur and corporate finance executive with 30 years of combined experience in capital markets, public accounting and in the private sector. She currently

    5/21/24 8:30:00 AM ET
    $ALBT
    $LRHC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Real Estate
    Finance

    $ALBT
    Financials

    Live finance-specific insights

    View All

    Avalon GloboCare Acquires RPM Interactive, a Generative AI Software Company, in an All-Stock Transaction

    Company forms a new subsidiary, Avalon Quantum AI, LLC, in connection with the acquisition Acquisition expected to resolve Nasdaq minimum stockholders' equity deficiency RPM Interactive has developed a fully automated, generative AI powered SaaS platform for creating short-form video content FREEHOLD, N.J., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of precision diagnostic consumer products, today announced that it has acquired RPM Interactive, Inc. ("RPM"), a generative artificial intelligence ("AI") publishing and software company, in an all-stock transaction. As a result of the acquisition, the Company believes it

    12/15/25 8:30:00 AM ET
    $ALBT
    $ASPU
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Other Consumer Services
    Consumer Discretionary

    Avalon's Laboratory Services MSO Acquires California-Based Medical Supply Company and Proprietary FDA-Registered External Male Catheter Device

    FREEHOLD, N.J., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative precision diagnostics and provider of clinical laboratory services, today announced Laboratory Services MSO, LLC ("LSM"), has acquired Merlin Medical Supply ("MMS"), a profitable, well-established Home Medical Equipment ("HME") and Durable Medical Equipment ("DME") company providing acute and non-acute medical supplies in Ventura County, California. Additionally, LSM has acquired Leading Edge Innovations, LLC from the same owner. Leading Edge Innovations owns the GeeWhiz External Condom Catheter, a patented, FDA-registered, in-market, male incontine

    9/13/23 9:15:00 AM ET
    $ALBT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Avalon's Laboratory Services MSO Acquires Texas Lab with Significant Potential Growth

    FREEHOLD, N.J., July 24, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative precision diagnostics and provider of clinical laboratory services, today announced Laboratory Services MSO, LLC ("LSM"), has acquired DE Laboratory LLC ("DE Labs"), which expands its penetration within Texas and provides significant potential growth opportunities for the combined company. Avalon owns a 40% interest in LSM. DE Labs is a CLIA-certified and COLA-accredited laboratory located in Houston, Texas that offers a wide range of high-quality testing, including drug testing, genetic testing, urinary testing and COVID-19 PCR testing. LSM is no

    7/24/23 9:00:00 AM ET
    $ALBT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care